EOLS FY 2021 Earnings — Evolus, Inc. Revenue & Financial Results | Market Cap Arena

EOLSEvolus, Inc.

$353M

FY 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$100M+76.3% YoY

Gross Profit

$56M56.3% margin

Operating Income

-$44M-44.6% margin

Net Income

-$47M-47.0% margin

EPS (Diluted)

$-0.94

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$34M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$257M

Total Liabilities

$176M

Stockholders' Equity

$82M

Cash & Equivalents

$146M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$100M	$57M	+76.3%
Gross Profit	$56M	$38M	+46.8%
Operating Income	-$44M	-$153M	+71.0%
Net Income	-$47M	-$163M	+71.3%